These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9871605)

  • 1. 5-Aminomethylquinoxaline-2,3-diones, Part III: Arylamide derivatives as highly potent and selective glycine-site NMDA receptor antagonists.
    Acklin P; Allgeier H; Auberson YP; Bischoff S; Ofner S; Sauer D; Schmutz M
    Bioorg Med Chem Lett; 1998 Mar; 8(5):493-8. PubMed ID: 9871605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Aminomethylquinoxaline-2,3-diones. Part II: N-aryl derivatives as novel NMDA/glycine and AMPA antagonists.
    Auberson YP; Acklin P; Allgeier H; Biollaz M; Bischoff S; Ofner S; Veenstra SJ
    Bioorg Med Chem Lett; 1998 Jan; 8(1):71-4. PubMed ID: 9871631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
    Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Aminomethylquinoxaline-2,3-diones. Part I: A novel class of AMPA receptor antagonists.
    Auberson YP; Bischoff S; Moretti R; Schmutz M; Veenstra SJ
    Bioorg Med Chem Lett; 1998 Jan; 8(1):65-70. PubMed ID: 9871630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
    Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
    J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of 1,4-dihydro-(1H,4H)-quinoxaline-2,3-diones as N-methyl-D-aspartate (glycine site) receptor antagonists. 1. Heterocyclic substituted 5-alkyl derivatives.
    Fray MJ; Bull DJ; Carr CL; Gautier EC; Mowbray CE; Stobie A
    J Med Chem; 2001 Jun; 44(12):1951-62. PubMed ID: 11384240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of substituted 1,4-dihydroquinoxaline-2,3-diones: antagonists of N-methyl-D-aspartate (NMDA) receptor glycine sites and non-NMDA glutamate receptors.
    Keana JF; Kher SM; Cai SX; Dinsmore CM; Glenn AG; Guastella J; Huang JC; Ilyin V; Lü Y; Mouser PL
    J Med Chem; 1995 Oct; 38(22):4367-79. PubMed ID: 7473565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-(N-oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: novel, systemically active and broad spectrum antagonists for NMDA/glycine, AMPA, and kainate receptors.
    Cai SX; Huang JC; Espitia SA; Tran M; Ilyin VI; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Oct; 40(22):3679-86. PubMed ID: 9357535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tricyclic quinoxalinediones: 5,6-dihydro-1H-pyrrolo[1,2,3-de] quinoxaline-2,3-diones and 6,7-dihydro-1H,5H-pyrido[1,2,3-de] quinoxaline-2,3-diones as potent antagonists for the glycine binding site of the NMDA receptor.
    Nagata R; Tanno N; Kodo T; Ae N; Yamaguchi H; Nishimura T; Antoku F; Tatsuno T; Kato T; Tanaka Y
    J Med Chem; 1994 Nov; 37(23):3956-68. PubMed ID: 7966156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of ACEA-1416: a potent systemically active NMDA receptor glycine site antagonist.
    Ilyin VI; Whittemore ER; Tran M; Shen KZ; Cai SX; Kher SM; Keana JF; Weber E; Woodward RM
    Eur J Pharmacol; 1996 Aug; 310(2-3):107-14. PubMed ID: 8884205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spiro-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives are mixed AMPA and NMDA glycine-site antagonists active in vivo.
    Jimonet P; Boireau A; Chevé M; Damour D; Genevois-Borella A; Imperato A; Pratt J; Randle JC; Ribeill Y; Stutzmann JM; Mignani S
    Bioorg Med Chem Lett; 1999 Oct; 9(20):2921-6. PubMed ID: 10571148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
    Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
    Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and SAR of novel di- and trisubstituted 1,4-dihydroquinoxaline-2,3-diones related to licostinel (Acea 1021) as NMDA/glycine site antagonists.
    Zhou ZL; Kher SM; Cai SX; Whittemore ER; Espitia SA; Hawkinson JE; Tran M; Woodward RM; Weber E; Keana JF
    Bioorg Med Chem; 2003 Apr; 11(8):1769-80. PubMed ID: 12659763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor.
    Leeson PD; Baker R; Carling RW; Curtis NR; Moore KW; Williams BJ; Foster AC; Donald AE; Kemp JA; Marshall GR
    J Med Chem; 1991 Apr; 34(4):1243-52. PubMed ID: 1826744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of 1,2,3,4-tetrahydroquinoline-2,3,4-trione 3-oximes: novel and highly potent antagonists for NMDA receptor glycine site.
    Cai SX; Zhou ZL; Huang JC; Whittemore ER; Egbuwoku ZO; Lü Y; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1996 Aug; 39(17):3248-55. PubMed ID: 8765507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel NMDA/glycine site antagonists attenuate cocaine-induced behavioral toxicity.
    Matsumoto RR; Brackett RL; Kanthasamy AG
    Eur J Pharmacol; 1997 Nov; 338(3):233-42. PubMed ID: 9424017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sites.
    Guzikowski AP; Cai SX; Espitia SA; Hawkinson JE; Huettner JE; Nogales DF; Tran M; Woodward RM; Weber E; Keana JF
    J Med Chem; 1996 Nov; 39(23):4643-53. PubMed ID: 8917653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Nitro-3,4-dihydro-2(1H)-quinolones. Excitatory amino acid antagonists acting at glycine-site NMDA and (RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
    Carling RW; Leeson PD; Moore KW; Smith JD; Moyes CR; Mawer IM; Thomas S; Chan T; Baker R; Foster AC
    J Med Chem; 1993 Oct; 36(22):3397-408. PubMed ID: 8230130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
    Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
    Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.